نتایج جستجو برای: vegf receptor 2

تعداد نتایج: 2961377  

2015
Caren Jayasinghe Nektaria Simiantonaki Sylvia Habedank Charles James Kirkpatrick

BACKGROUND For the successful therapeutic use of inhibitors of the vascular endothelial growth factor receptor (VEGFR) pathway detailed knowledge of the mechanisms leading to tumor progression is indispensable. The main goal of this study was to determine the relevance of the VEGFR-2 activating pathway for colon carcinoma (CC) metastasis. The initial event is ligand-induced receptor activation ...

Journal: :Circulation 2013
Andrey Anisimov Denis Tvorogov Annamari Alitalo Veli-Matti Leppänen Yuri An Eun Chun Han Fabrizio Orsenigo Emília Ilona Gaál Tanja Holopainen Young Jun Koh Tuomas Tammela Petra Korpisalo Salla Keskitalo Michael Jeltsch Seppo Ylä-Herttuala Elisabetta Dejana Gou Young Koh Chulhee Choi Pipsa Saharinen Kari Alitalo

BACKGROUND There is an unmet need for proangiogenic therapeutic molecules for the treatment of tissue ischemia in cardiovascular diseases. However, major inducers of angiogenesis such as vascular endothelial growth factor (VEGF/VEGF-A) have side effects that limit their therapeutic utility in vivo, especially at high concentrations. Angiopoietin-1 has been considered to be a blood vessel stabil...

Journal: :American journal of physiology. Heart and circulatory physiology 2004
Chandrani Sarkar Debanjan Chakroborty Rita Basu Mitra Samir Banerjee Partha Sarathi Dasgupta Sujit Basu

Vascular permeability factor (VPF)/VEGF is a potent multifunctional cytokine and growth factor that has critical roles in vasculogenesis and in both physiological and pathological angiogenesis. Because it has been recently shown that the neurotransmitter dopamine at pharmacological dose can inhibit VEGF/VPF-mediated microvascular permeability, proliferation, and migration of endothelial cells i...

Journal: :The Journal of clinical investigation 2000
Y Kasahara R M Tuder L Taraseviciene-Stewart T D Le Cras S Abman P K Hirth J Waltenberger N F Voelkel

Pulmonary emphysema, a significant global health problem, is characterized by a loss of alveolar structures. Because VEGF is a trophic factor required for the survival of endothelial cells and is abundantly expressed in the lung, we hypothesized that chronic blockade of VEGF receptors could induce alveolar cell apoptosis and emphysema. Chronic treatment of rats with the VEGF receptor blocker SU...

Journal: :Investigative ophthalmology & visual science 2002
Antonella N Witmer Harriet G Blaauwgeers Herbert A Weich Kari Alitalo Gijs F J M Vrensen Reinier O Schlingemann

PURPOSE The vascular endothelial growth factor (VEGF) family is involved in vascular leakage and angiogenesis in diabetic retinopathy (DR) in the eye, but may also have physiological functions. Based on the hypothesis that differential VEGF receptor (VEGFR) expression in the retina is an important determinant of effects of VEGF, this study was conducted to investigate VEGFR expression in the di...

Journal: :The EMBO journal 2012
Guo-Xiang Ruan Andrius Kazlauskas

Herein, we report that vascular endothelial growth factor A (VEGF-A) engages the PI3K/Akt pathway by a previously unknown mechanism that involves three tyrosine kinases. Upon VEGF-A-dependent activation of VEGF receptor-2 (VEGFR-2), and subsequent TSAd-mediated activation of Src family kinases (SFKs), SFKs engage the receptor tyrosine kinase Axl via its juxtamembrane domain to trigger ligand-in...

Journal: :PLoS ONE 2009
Efstathios Karathanasis Leslie Chan Lohitash Karumbaiah Kathleen McNeeley Carl J. D'Orsi Ananth V. Annapragada Ioannis Sechopoulos Ravi V. Bellamkonda

BACKGROUND Vascular endothelial growth factor (VEGF) receptor-2 is the major mediator of the mitogenic, angiogenic, and vascular hyperpermeability effects of VEGF on breast tumors. Overexpression of VEGF and VEGF receptor-2 is associated with the degree of pathomorphosis of the tumor tissue and unfavorable prognosis. In this study, we demonstrate that non-invasive quantification of the degree o...

Journal: :Annales Academiae Medicae Silesiensis 2022

Wstęp Angiogeneza nowotworowa jest procesem regulowanym przez wiele cytokin i czynników wzrostu, spośród których znaczącą rolę odgrywają czynnik wzrostu śródbłonka naczyń (<i>vascular endothelial growth factor</i> – VEGF), drugi rozpuszczalny receptor dla śródbłonkowego czynnika (<i>soluble vascular factor 2</i> sVEGFR-2) galektyna-3. Dane literaturowe dotyczące oceny zm...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید